TCIM
ANGO icon

TIAA CREF Investment Management’s AngioDynamics ANGO Stock Holding History

TIAA CREF Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.64M Sell
115,550
-3,319
-3% -$72.1K ﹤0.01% 1839
2018
Q4 		$2.39M Sell
118,869
-30,980
-21% -$641K ﹤0.01% 1848
2018
Q3 		$3.26M Sell
149,849
-40,816
-21% -$907K ﹤0.01% 1864
2018
Q2 		$4.24M Sell
190,665
-5,928
-3% -$121K ﹤0.01% 1722
2018
Q1 		$3.39M Sell
196,593
-54,447
-22% -$908K ﹤0.01% 1807
2017
Q4 		$4.17M Sell
251,040
-38,945
-13% -$665K ﹤0.01% 1718
2017
Q3 		$4.96M Buy
289,985
+825
+0.3% +$13.9K ﹤0.01% 1627
2017
Q2 		$4.69M Buy
289,160
+55,444
+24% +$877K ﹤0.01% 1637
2017
Q1 		$4.05M Buy
233,716
+58,345
+33% +$976K ﹤0.01% 1723
2016
Q4 		$2.96M Buy
175,371
+42,987
+32% +$717K ﹤0.01% 1962
2016
Q3 		$2.32K Buy
132,384
+9,051
+7% +$147K ﹤0.01% 2083
2016
Q2 		$1.77M Buy
123,333
+1,585
+1% +$19.8K ﹤0.01% 2200
2016
Q1 		$1.5M Buy
121,748
+15,790
+15% +$174K ﹤0.01% 2244
2015
Q4 		$1.29M Sell
105,958
-3,791
-3% -$46.7K ﹤0.01% 2430
2015
Q3 		$1.45M Buy
109,749
+7,853
+8% +$119K ﹤0.01% 2341
2015
Q2 		$1.67M Sell
101,896
-8,641
-8% -$143K ﹤0.01% 2409
2015
Q1 		$1.97M Sell
110,537
-2,343
-2% -$43.5K ﹤0.01% 2227
2014
Q4 		$2.15M Sell
112,880
-665
-0.6% -$11.3K ﹤0.01% 2182
2014
Q3 		$1.56M Sell
113,545
-25,235
-18% -$360K ﹤0.01% 2383
2014
Q2 		$2.27M Buy
138,780
+8,719
+7% +$126K ﹤0.01% 2231
2014
Q1 		$2.05M Sell
130,061
-4,012
-3% -$65.4K ﹤0.01% 2219
2013
Q4 		$2.31M Buy
134,073
+8,462
+7% +$130K ﹤0.01% 2174
2013
Q3 		$1.66M Buy
125,611
+11,454
+10% +$135K ﹤0.01% 2330
2013
Q2 		$1.29M Buy
+114,157
New +$1.21M ﹤0.01% 2420

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

TIAA CREF Investment Management's ANGO Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its AngioDynamics (ANGO) stake by 2.8% in Q1 2019, selling an estimated $72.1K and leaving 115,550 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

TIAA CREF Investment Management first reported a position in ANGO in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.96M in Q3 2017. 179 funds tracked by Wall St. Rank hold ANGO as of Q1 2019.

  • TIAA CREF Investment Management held 115,550 shares of AngioDynamics worth $2.64M as of Q1 2019.
  • TIAA CREF Investment Management sold 3,319 AngioDynamics shares in Q1 2019, an estimated $72.1K.
  • AngioDynamics made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1839 holding.
  • TIAA CREF Investment Management first reported a position in AngioDynamics in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's AngioDynamics position peaked at $4.96M in Q3 2017.
  • 179 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.